Cardiovascular Diseases Clinical Trial
To test whether a behavioral intervention could indeed achieve the dual goals of promoting smoking cessation and minimizing weight gain.
BACKGROUND:
When the study began in 1995, more females were initiating cigarette smoking, and a growing
proportion cited fear of gaining weight as a major reason for refusing to even attempt
quitting smoking. It had not yet been possible, however, to prevent post- cessation weight
gain through dieting or behavioral treatment without undermining abstinence from smoking.
The investigators proposed that prior interventions had been unsuccessful because: (a) their
weight management interventions were too complex; (b) the programs thwarted a need of the
patient in nicotine withdrawal to eat hedonically appealing, high-carbohydrate snacks; and
(c) the programs heightened patients' emphasis on weight control at the expense of their
emphasis on smoking cessation by asking them to initiate weight control before or
simultaneously with quitting smoking.
DESIGN NARRATIVE:
The investigators collected pilot data on a promising 16-week intervention that they called
the LATE WEIGHT PLAN because it emphasized smoking cessation for the first half of treatment
and integrated weight management for the last half. The weight management module included a
pre-packaged meal plan; high-carbohydrate, low-fat snacks; and low-intensity aerobic
exercise. All patients continued in the weight management phase of treatment, regardless of
whether they had succeeded in quitting smoking or were preparing to make new quit attempts.
Based on pilot findings, the investigators estimated the point prevalence of smoking
cessation for the LATE WEIGHT PLAN group to be 74% at the end of treatment, with weight gain
less than 5 lb. An EARLY WEIGHT PLAN group controlled for the timing of the intervention,
using the same target quit smoking date and 16 week program but integrating the weight
management module into the first 8 weeks of treatment. Like others, they found that EARLY
weight management efforts, while they may have prevented weight gain, apparently did so at
some cost to smoking cessation, which they estimated to be 42% at 4 months. Finally, a
CESSATION ONLY group controlled for the presence of a weight management intervention, by
dealing exclusively with smoking cessation for the entire 16 week program. The CESSATION
ONLY group had attained the worst outcome in terms of weight control and an intermediate
outcome in terms of abstinence at the end of treatment (50%). By randomizing 315 female
smokers to the three treatments and comparing abstinence and weight gain after 4 months of
treatment and 6 month follow-up (10 months), they tested whether a behavioral intervention
could indeed achieve the dual goals of promoting smoking cessation and minimizing weight
gain.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
Allocation: Randomized, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|